| Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia NC Hegde, A Kumar, S Kaundal, L Saha, P Malhotra, S Prinja, D Lad, ... Annals of Hematology, 1-8, 2023 | 5 | 2023 |
| Essential oil nebulization in mild COVID-19 (EONCO): Early phase exploratory clinical trial R Rathod, R Mohindra, A Vijayakumar, RK Soni, R Kaur, A Kumar, ... Journal of Ayurveda and Integrative Medicine 13 (3), 100626, 2022 | 5 | 2022 |
| Developing a latent class analysis model to identify at-risk populations among people using medicine without prescription P Kumar-M, R Mahajan, S Kathirvel, N Hegde, AK Kakkar, AN Patil Expert Review of Clinical Pharmacology 13 (12), 1411-1422, 2020 | 4 | 2020 |
| Rationalizing the Use of COVID-19 Questionable Efficacy Drugs in a Low Middle-income Country: A Hospital Tocilizumab Committee Experience. N Hegde, A Kumar, GK Batra, M Devnani, R Rohilla, P Malhotra, AN Patil The Journal of the Association of Physicians of India 71 (3), 11-12, 2023 | 3 | 2023 |
| Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis NC Hegde, A Kumar, AN Patil, S Bhattacharjee, N Gamad, KS Kasudhan, ... Acta Diabetologica, 1-21, 2023 | 2 | 2023 |
| Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial A Anand, NC Hegde, P Chhabra, J Purohit, R Kumar, A Gupta, DP Lad, ... Annals of Hematology, 1-12, 2024 | | 2024 |
| Comparison of master two-step exercise stress test versus six-min walk test in patients tested positive for SARS-CoV-2 A Kumar, N Hegde, J Kumaravel, R Mohindra, RK Soni, R Rathod, ... Journal of Family Medicine and Primary Care 11 (11), 7008, 2022 | | 2022 |
